Health Care Archives - Page 16 of 478

2 minute read

Johnson & Johnson’s Bankruptcy Tactics Are Fraudulent, Plaintiffs Accuse Company Of Defrauding Cancer Victims

May 23, 11:26 AM

Cancer victims have filed a lawsuit against Johnson & Johnson, accusing the company of fraudulently using a shell company's bankruptcy to evade lawsuits. The plaintiffs claim the "Texas two-step" maneuver was designed to protect J&J's assets from litigation.

JNJ

2 minute read

Medtronic’s Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend

By Vandana Singh

May 23, 11:14 AM

Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50.

MDT

2 minute read

Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027

By Benzinga Neuro

May 23, 7:31 AM

The company disclosed the new program in a filing with the Securities and Exchange Commission.

PFE

2 minute read

Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M

By Vandana Singh

May 22, 1:25 PM

A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous $834 million judgment

BMY

2 minute read

Novo Nordisk’s Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review

By Vandana Singh

May 22, 1:21 PM

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee will review Novo Nordisk's application for once-weekly insulin icodec on May 24. Concerns include an increased risk of hypoglycemia in type 1 diabetes patients.

NVO

2 minute read

Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks’ Cells

By Vandana Singh

May 22, 12:27 PM

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against Ultragenyx's motion to dismiss, allowing the case to continue.

RARE

1 minute read

Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns

By Vandana Singh

May 22, 11:46 AM

Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia.

LLY

2 minute read

NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success

By Vandana Singh

May 22, 10:55 AM

NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.

NRBO

1 minute read

Why Is Pet Care Focused Petco Stock Trading Higher On Wednesday?

By Vandana Singh

May 22, 9:51 AM

Petco Health and Wellness reported Q1 2024 net revenue of $1.53 billion, nearly matching consensus and management guidance. Comparable sales dropped 1.2% yoy.

WOOF

2 minute read

Why Is Small-Cap Metabolic-Focused Rezolute Stock Trading Higher On Wednesday?

By Vandana Singh

May 22, 7:56 AM

Rezolute announced topline results from the Phase 2 study of RZ402 for diabetic macular edema, showing significant improvements in macular edema and a favorable safety profile.

RZLT